| Business Summary | | Langer
Inc.
is
engaged
in
the
design,
manufacture
and
marketing
of
foot
and
gait-related
biomechanical
products.
The
Company's
largest
product
line
is
comprised
of
custom-made,
prescription
orthotic
devices.
In
addition
to
its
line
of
orthotics
products,
the
Company
has
developed
and
markets
a
number
of
other
products
that
help
treat
biomechanical
medical
problems
related
to
feet
and
gait,
including
PPT
Medical
Grade
Soft
Tissue
Supplement,
and
CRS
Pediatric
Counter
Rotation
Splint.
The
Company's
customers
are
primarily
podiatrists,
and
also
include
orthopedists,
physical
therapists
and
Orthotic
&
Prosthetic
centers. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Langer
Inc.
designs,
manufactures
and
markets
a
variety
of
foot
and
gait
related
biomechanical
products.
For
the
three
months
ended
5/26/01,
net
sales
increased
10%
to
$3
million.
Net
income
totaled
$10
thousand
vs.
a
loss
of
$44
thousand.
Revenues
reflect
increased
unit
volumes
of
orthotic
sales.
Net
income
also
reflects
a
decrease
in
R&D
expenses
due
to
the
absence
of
costs
associated
with
modifications
to
new
manufacturing
processes. | More
from
Market Guide: Significant
Developments |
| | | | FY2001 Pay | |
| Burtt Ehrlich, 61 Chairman | -- | Andrew Meyers, 44 Pres,
CEO, Director | $6.7K | Thomas Archbold, 41 CFO,
VP-Fin. | 145.4K | Steven Goldstein, 35 VP,
Sec. | -- | Dollar amounts are as of 28-Feb-2001 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|